Pioneer Group
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
NunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale
NunaBio develops an enzymatic DNA synthesis platform that manufactures high fidelity synthetic DNA at scale. The platform enables customers in sectors such as medicine, biotechnology and diagnostics to access complex DNA formats that are difficult to produce using traditional methods.
NuVision Biotherapies unlocks £4.8m in funding led by Mercia Ventures to speed up the healing of eye conditions
NuVision Biotherapies develops ophthalmic products based on amniotic membrane tissue. Its treatments are used to support healing after eye surgery and manage chronic eye conditions.
ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing
ImmuONE provides a 3D human lung laboratory model that replaces animal testing, allowing companies to assess respiratory safety, inflammation and long-term effects of chemicals, drugs and consumer products more reliably.
More venture news
- 25 Jun 2026
HR DuoHR Duo secures £1.4m in funding led by Puma Growth Partners to build workforce management platform for frontline-heavy SMEs
EquityHR - 23 Jun 2026
LabCycleLabCycle raises £180k from British Design Fund to scale circular recycling system for contaminated laboratory plastics
EquityClimate - 19 Jan 2026
LabCycleLabCycle unlocks funding from Angel Academe to solve the circular recycling of laboratory plastic waste
EquityClimate
